Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
 
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 13288 times
PR Category : Healthcare & Medicine
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Acc...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Stay Protected from Increasing Gold Rates with Malabar Gold & Diamonds [9307-Views]
Emirates Increases Flights to Riyadh for Saudi National Day [4088-Views]
Danube Home Unveils the Exciting My Garden Collection for 2024 [3649-Views]
Dubai Sports Council & International Cricket Council discuss ways of boosting Common Coope... [3378-Views]
DAE Announces Closing of US$1.6 Billion New Financing Facilities [3362-Views]
Joyalukkas Announces Happy Diamonds Promotion with 100% Value Assurance on Diamond Exchang... [3341-Views]
OMEGA's Latest Seamaster Salutes Emirates Team New Zealand [3280-Views]
Abrahamic Family House Announces Programming to Foster Interfaith Dialogue and Inspire Und... [3177-Views]
Al Masaood Automobiles Witnesses Strong Growth for Nissan Certified Pre-Owned Vehicles wit... [3153-Views]
King of the Table 8” Arm-wrestling Legends John Brzenk and Alexey Voyevoda Collide for a J... [3145-Views]
Marina Rinaldi FW 23 X Mary Katrantzou [3120-Views]
Akillis Rendez-Vous Campaign Featuring Capture Collection [3095-Views]
Emirates Engages Experienced Captains to Fly the Airline's Future Fleet [3022-Views]
Mohammed Bin Rashid Library Launches ‘A World in Your Language' Initiative to Read and Lis... [2981-Views]
ADU's College of Business Rolls Out Five Programs for Undergraduate Students [2977-Views]
The Tamkeen Real Estate Programme Workshop Empowers understanding of ‘Nafis' and Reinforce... [2968-Views]
Emirates and SriLankan Establish Reciprocal Interline Partnership [2960-Views]
Juan Manuel Fangio's Victory 70 Years Ago Aboard a Maserati at the Italian Grand Prix [2931-Views]
Bax takes daring Victory and Hirschi Finishes Second in Italy as Ayuso concludes a strong ... [2931-Views]
The Grand Symphony of Wheels: GIMS Qatar 2023 Roars to Life in Doha [2931-Views]
Danah Bay Introduces First-ever Breakwater Villas and Exclusive Landside Villas in Ras Al ... [2890-Views]
Dubai Municipality Participates in “Ru'ya 2023 Careers UAE Redefined” [2886-Views]
Emirates Scores with Beirut Basketball Club in a Multi-year Sponsorship [2858-Views]
Nirvikar Films Unveils a Gripping Tale of Intrigue in "Aakhri Sach" - A Blockbus... [2788-Views]
Al Ansari Exchange Crowns 10th Millionaire of Summer Promotion [2763-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Top Sections
 
Top Stories